179 related articles for article (PubMed ID: 30825519)
1. Links between aldosterone excess and metabolic complications: A comprehensive review.
Bothou C; Beuschlein F; Spyroglou A
Diabetes Metab; 2020 Feb; 46(1):1-7. PubMed ID: 30825519
[TBL] [Abstract][Full Text] [Related]
2. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
[TBL] [Abstract][Full Text] [Related]
3. Secondary diabetes mellitus due to primary aldosteronism.
Moustaki M; Paschou SA; Vakali EC; Vryonidou A
Endocrine; 2023 Jan; 79(1):17-30. PubMed ID: 36001240
[TBL] [Abstract][Full Text] [Related]
4. Primary aldosteronism and metabolic syndrome.
Fallo F; Pilon C; Urbanet R
Horm Metab Res; 2012 Mar; 44(3):208-14. PubMed ID: 22116746
[TBL] [Abstract][Full Text] [Related]
5. The metabolic syndrome in primary aldosteronism.
Fallo F; Federspil G; Veglio F; Mulatero P
Curr Hypertens Rep; 2007 Apr; 9(2):106-11. PubMed ID: 17442220
[TBL] [Abstract][Full Text] [Related]
6. The metabolic syndrome in primary aldosteronism.
Fallo F; Federspil G; Veglio F; Mulatero P
Curr Diab Rep; 2008 Feb; 8(1):42-7. PubMed ID: 18366998
[TBL] [Abstract][Full Text] [Related]
7. Associations Between Metabolic Profiles and Target-Organ Damage in Chinese Individuals With Primary Aldosteronism.
Zhang SL; Gao JW; Guo Y; Feng QL; Tang JY; Yan L; Wang JF; Cheng H; Liu PM
Front Endocrinol (Lausanne); 2020; 11():547356. PubMed ID: 33101195
[No Abstract] [Full Text] [Related]
8. Metabolic syndrome in primary aldosteronism and essential hypertension: relationship to adiponectin gene variants.
Ronconi V; Turchi F; Rilli S; Di Mattia D; Agostinelli L; Boscaro M; Giacchetti G
Nutr Metab Cardiovasc Dis; 2010 Feb; 20(2):93-100. PubMed ID: 19481913
[TBL] [Abstract][Full Text] [Related]
9. [Role of aldosterone in the metabolic syndrome].
Mulatero P; Bertello C; Verhovez A; Testa E; Puglisi E; Morello F; Monticone S; Fallo F; Veglio F
G Ital Nefrol; 2006; 23(4):406-14. PubMed ID: 17063441
[TBL] [Abstract][Full Text] [Related]
10. The effect of aldosterone on glucose metabolism.
Corry DB; Tuck ML
Curr Hypertens Rep; 2003 Apr; 5(2):106-9. PubMed ID: 12642008
[TBL] [Abstract][Full Text] [Related]
11. Hyperaldosteronism: a commonly occurring underlying feature of essential hypertension and the metabolic syndrome?
Chun TY; Pratt JH
Curr Opin Endocrinol Diabetes Obes; 2007 Jun; 14(3):210-2. PubMed ID: 17940441
[TBL] [Abstract][Full Text] [Related]
12. A possible association between primary aldosteronism and a lower beta-cell function.
Mosso LM; Carvajal CA; Maiz A; Ortiz EH; Castillo CR; Artigas RA; Fardella CE
J Hypertens; 2007 Oct; 25(10):2125-30. PubMed ID: 17885557
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study.
Fallo F; Dalla Pozza A; Tecchio M; Tona F; Sonino N; Ermani M; Catena C; Bertello C; Mulatero P; Sabato N; Fabris B; Sechi LA
Am J Hypertens; 2010 Jan; 23(1):2-5. PubMed ID: 19910932
[TBL] [Abstract][Full Text] [Related]
14. Aldosterone excess may inhibit insulin secretion: A comparative study on glucose metabolism pre- and post-adrenalectomy in patients with primary aldosteronism.
Tsurutani Y; Sugisawa C; Ishida A; Inoue K; Saito J; Omura M; Nagasaka S; Nishikawa T
Endocr J; 2017 Mar; 64(3):339-346. PubMed ID: 28111382
[TBL] [Abstract][Full Text] [Related]
15. Glucose Metabolism in Primary Aldosteronism.
Remde H; Hanslik G; Rayes N; Quinkler M
Horm Metab Res; 2015 Dec; 47(13):987-93. PubMed ID: 26667801
[TBL] [Abstract][Full Text] [Related]
16. Aldosterone and type 2 diabetes mellitus.
Zavatta G; Casadio E; Rinaldi E; Pagotto U; Pasquali R; Vicennati V
Horm Mol Biol Clin Investig; 2016 Apr; 26(1):53-9. PubMed ID: 26876814
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin and insulin sensitivity in primary aldosteronism.
Fallo F; Della Mea P; Sonino N; Bertello C; Ermani M; Vettor R; Veglio F; Mulatero P
Am J Hypertens; 2007 Aug; 20(8):855-61. PubMed ID: 17679033
[TBL] [Abstract][Full Text] [Related]
18. Aldosterone, mineralocorticoid receptor and the metabolic syndrome: role of the mineralocorticoid receptor antagonists.
Ronconi V; Turchi F; Appolloni G; di Tizio V; Boscaro M; Giacchetti G
Curr Vasc Pharmacol; 2012 Mar; 10(2):238-46. PubMed ID: 22022770
[TBL] [Abstract][Full Text] [Related]
19. Aldosterone excess impairs first phase insulin secretion in primary aldosteronism.
Fischer E; Adolf C; Pallauf A; Then C; Bidlingmaier M; Beuschlein F; Seissler J; Reincke M
J Clin Endocrinol Metab; 2013 Jun; 98(6):2513-20. PubMed ID: 23539730
[TBL] [Abstract][Full Text] [Related]
20. The Aldosterone/Renin Ratio Predicts Cardiometabolic Disorders in Subjects Without Classic Primary Aldosteronism.
Vecchiola A; Fuentes CA; Barros ER; Martínez-Aguayo A; García H; Allende F; Solari S; Olmos R; Carvajal C; Tapia-Castillo A; Campino C; Kalergis AM; Baudrand R; Fardella CE
Am J Hypertens; 2019 Apr; 32(5):468-475. PubMed ID: 30753255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
